• EU approves new option for metastatic melanoma pharmatimes
    September 27, 2018
    The European Commission (EC) has granted marketing authorisation for Pierre Fabre’s Braftovi and Mektovi combination therapy for the treatment of adults...
PharmaSources Customer Service